Summary: BUSINESS STRATEGY In cancer treatment targets at discovery stage now makes up half the licensing deals with the typical terms exceeding $100 million NextGen is engaged in the development and commercial licensure of novel therapeutic proteins that disrupt the growth of cancers Our drug and product portfolio includes a prostate
Image Dimensions: 423 x 476
Image originally found here.